Correction: Identification of acrylamide-based covalent inhibitors of SARS-CoV-2 (SCoV-2) Nsp15 using high-throughput screening and machine learning

Teena Bajaj; Babak Mosavati; Lydia H. Zhang; Mohammad S. Parsa; Huanchen Wang; Evan M. Kerek; Xueying Liang; Seyed Amir Tabatabaei Dakhili; Eddie Wehri; Silin Guo; Rushil N. Desai; Lauren M. Orr; Mohammad R. K. Mofrad; Julia Schaletzky; John R. Ussher; Xufang Deng; Robin Stanley; Basil P. Hubbard; Daniel K. Nomura; Niren Murthy

doi:10.1039/D5RA90098K

Correction: Identification of acrylamide-based covalent inhibitors of SARS-CoV-2 (SCoV-2) Nsp15 using high-throughput screening and machine learning

Teena Bajaj,^a Babak Mosavati,^bc Lydia H. Zhang,^d Mohammad S. Parsa,^e Huanchen Wang,^f Evan M. Kerek,^g Xueying Liang,^h Seyed Amir Tabatabaei Dakhili,ⁱ Eddie Wehri,^j Silin Guo,^k Rushil N. Desai,^c Lauren M. Orr,^k Mohammad R. K. Mofrad,^l Julia Schaletzky,^jm John R. Ussher,ⁱ Xufang Deng,^h Robin Stanley,^f Basil P. Hubbard,^g Daniel K. Nomura^k and Niren Murthy*^bc

Author affiliations

* Corresponding authors

^a Graduate Program of Comparative Biochemistry, University of California, Berkeley, Berkeley, CA, USA
E-mail: bajajtiya@berkeley.edu

^b Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA, USA
E-mail: bmosavati@berkeley.edu

^c Department of Bioengineering, University of California, Berkeley, Berkeley, CA, USA
E-mail: nmurthy@berkeley.edu

^d Graduate Program of Molecular Toxicology, University of California, Berkeley, Berkeley, CA, USA

^e Department of Applied Science and Technology, University of California, Berkeley, CA, USA

^f Signal Transduction Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, North Carolina, USA

^g Department of Pharmacology, Li Ka Shing Institute of Virology, University of Alberta, Edmonton, Alberta, Canada

^h Department of Physiological Sciences, College of Veterinary Medicine, Oklahoma Center for Respiratory and Infectious Disease, Oklahoma State University, Oklahoma, USA

ⁱ Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada

^j The Henry Wheeler Center for Emerging and Neglected Diseases, University of California, Berkeley, Berkeley, CA, USA

^k Department of Chemistry, University of California, Berkeley, Berkeley, CA, USA

^l Department of Mechanical Engineering, University of California, Berkeley, CA, USA

^m The Molecular Therapeutics Initiative, University of California, Berkeley, 344 Li Ka Shing, Berkeley, CA, USA

Abstract

Correction for ‘Identification of acrylamide-based covalent inhibitors of SARS-CoV-2 (SCoV-2) Nsp15 using high-throughput screening and machine learning’ by Teena Bajaj et al., RSC Adv., 2025, 15, 10243–10256, https://doi.org/10.1039/D4RA06955B.

RSC Advances

Correction: Identification of acrylamide-based covalent inhibitors of SARS-CoV-2 (SCoV-2) Nsp15 using high-throughput screening and machine learning

Abstract

Associated articles

Article information

Download Citation

Permissions

Correction: Identification of acrylamide-based covalent inhibitors of SARS-CoV-2 (SCoV-2) Nsp15 using high-throughput screening and machine learning

Social activity

Search articles by author

Spotlight

Advertisements